ChemoCentryx Announces Plenary Session at ACR Convergence 2020 to Highlight Findings of ADVOCATE Phase III Trial in ANCA-...
-- Study Showed Treatment with Avacopan Achieved Statistical Superiority in Sustaining Remission at 52 Weeks and Greater Improvement in Renal Function Compared to the Prednisone Group -- MOUNTAIN VIEW, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx …